Avita Medical, Inc. (RCEL) fundamentals score
AVITA Medical is a leading therapeutic acute wound care company delivering transformative solutions designed to optimize wound healing, accelerate patient recovery, and improve clinical and economic outcomes across the continuum of acute wound management.
Surgical & Medical Instruments & Apparatus · Healthcare · Listed on NASDAQ
Overall: 4.4 out of 10, Weak long-term fundamentals
- Growth: 6.2/10
- Profitability: 3.8/10
- Financial health: 1.7/10
- Earnings quality: 7.4/10
- Valuation: 3.1/10
Scores are calculated from Avita Medical, Inc.’s SEC filings, using the 12 months through 2026-06. Compare it with past big winners, check its flags, and see today’s price against its fundamentals in the full scorecard.
Other Healthcare stocks
- Nurix Therapeutics, Inc. (NRIX): 9.0/10
- Caredx, Inc. (CDNA): 8.9/10
- Dexcom, Inc. (DXCM): 8.8/10
- Exelixis Inc. (EXEL): 8.8/10
- Neurocrine Biosciences Inc. (NBIX): 8.7/10
- Progyny, Inc. (PGNY): 8.6/10
- Healthcare Services Group, Inc. (HCSG): 8.5/10
- Insulet Corporation (PODD): 8.5/10